Literature DB >> 27523419

[Radiotherapy for nasopharyngeal carcinoma].

P Maingon1, P Blanchard2, F Bidault3, L Calmels4.   

Abstract

Nasapharyngeal carcinoma is a rare disease. Oftenly, the diagnostic is made for advanced disease. Localized tumors, T1 or T2 NO observed a good prognosis and are locally controlled in more than 90 % of the cases by radiotherapy alone. The standard treatment of locally advanced disease is combined chemoradiation. A special vigilance of fast decrease of the volume of the pathological lymph nodes, sometimes associated to loss of weight might indicate an adaptive dosimetric revision. The treatment of recurrent disease is of great importance. Surgical indications are limited but should be discussed in multidisciplinary tumor board when possible. Surgical nodal sampling has to be proposed for nodal recurrence as well as reirradiation, which could be indicated according to the technical issues.
Copyright © 2016. Published by Elsevier SAS.

Entities:  

Keywords:  Adaptive radiotherapy; Chemoradiation; Intensity modulated radiotherapy; Nasopharynx; Radio-chimiothérapie; Radiothérapie adaptative; Radiothérapie avec modulation d’intensité

Mesh:

Year:  2016        PMID: 27523419     DOI: 10.1016/j.canrad.2016.07.031

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  2 in total

1.  Elevated pretreatment platelet distribution width and platelet count predict poor prognosis in nasopharyngeal carcinoma.

Authors:  XueCheng Xie; XiaoChun Zeng; SuJuan Cao; XiaoMao Hu; QiaoJing Shi; Dan Li; ShiYuan Zhou; Ping Gu; ZhongShan Zhang
Journal:  Oncotarget       Date:  2017-11-20

2.  Dosimetric comparison and observation of three-dimensional conformal radiotherapy for recurrent nasopharyngeal carcinoma.

Authors:  Rongqiang Pan; Jingming Wang; Feng Qi; Ruizhen Liu
Journal:  Oncol Lett       Date:  2017-08-08       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.